bch logo

Christie Enjey Lin, PhD, MA

Psychology (Child and Adolescent Psychology)
Autism & Neurodevelopmental Disorders Mission Bay
877-822-4453
Portrait of Christie Enjey Lin
Portrait of Christie Enjey Lin
bch logo

Christie Enjey Lin, PhD, MA

Psychology (Child and Adolescent Psychology)
Autism & Neurodevelopmental Disorders Mission Bay
877-822-4453

On this page

About me

Christie Enjey Lin is a psychologist who specializes in assessing and caring for people with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs). Her interests include understanding and addressing the overlap between core ASD features and psychiatric conditions that may occur at the same time, including anxiety; impaired behavioral flexibility and emotion regulation, such as insistence on sameness (the need or compulsion to do the same things again and again); and decreased overall adaptive functioning.

Lin completed her doctorate in clinical psychology at the University of California, Santa Barbara, with an emphasis in treating people with ASD and other NDDs. She completed a postdoctoral fellowship at the University of California, Los Angeles. She is a certified behavior analyst.

Before joining UCSF, Lin cared for patients at the UCLA Child and Adult Neurodevelopmental Clinic.

Education & training

Fellowship

  • Child Psychology, University of California at Los Angeles GME

Internship

  • Clinical Psychology, Stanford University Sleep Disorders Fellowship

Degree

  • PHD, University of California Santa Barbara

Academic Title

  • Health Sciences Clinical Professor

Locations

    My research

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.